Oculis Holding AG (OCS) Other Non Operating Income (2022 - 2026)

Oculis Holding AG's (OCS) quarterly Other Non Operating Income came in at $724061.7 in Q1 2026, up 141.54% year-on-year from $299764.4 in Q1 2025, and up 496.61% quarter-over-quarter from $121363.5 in Q4 2025.

Oculis Holding AG (OCS) Other Non Operating Income (2022 - 2026) Analysis & Trends

Oculis Holding AG's Other Non Operating Income history runs 5 years deep, the most recent figure standing at $724061.7 for Q1 2026.

  • On a quarterly basis, Other Non Operating Income rose 141.54% year-over-year to $724061.7 in Q1 2026; TTM through Mar 2026 was $2.5 billion, a 213.18% increase from a year earlier, with the FY2025 full-year figure at -$7.4 million, down 611.22% from the prior year.
  • Other Non Operating Income grew to $724061.7 in Q1 2026 per OCS's latest filing, from $121363.5 in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $2.5 billion in Q3 2025 and bottomed at -$2.2 billion in Q3 2024.
  • The 5-year median for Other Non Operating Income is -$278984.7 (2023), against an average of $17.8 million.
  • Biggest YoY gain for Other Non Operating Income was 882.33% in 2024; the steepest drop was 72670.47% in 2024.
  • Year by year, Other Non Operating Income stood at $3.3 million in 2022, then plunged by 174.35% to -$2.5 million in 2023, then surged by 175.75% to $1.9 million in 2024, then tumbled by 93.48% to $121363.5 in 2025, then surged by 496.61% to $724061.7 in 2026.
  • Per Business Quant, the three latest OCS Other Non Operating Income figures stand at $724061.7 (Q1 2026), $121363.5 (Q4 2025), and $2.5 billion (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn
7 Belite Bio 61.40 Bn 61.40 Bn -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn -
10 Alnylam Pharmaceuticals 36.08 Bn 33.07 Bn 959.66 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 724,061.65
Dec 31, 2025 121,363.47
Sep 30, 2025 2.47 Bn
Jun 30, 2025 -5.72 Mn
Mar 31, 2025 -1.74 Mn
Dec 31, 2024 1.86 Mn
Sep 30, 2024 -2.18 Bn
Jun 30, 2024 -295,246.86
Mar 31, 2024 2.06 Mn
Dec 31, 2023 -2.46 Mn
Sep 30, 2023 -2.99 Mn
Jun 30, 2023 453,767.62
Mar 31, 2023 -262,722.51
Dec 31, 2022 3.30 Mn
Sep 30, 2022 -1.35 Mn
Jun 30, 2022 -1.46 Mn